<DOC>
	<DOCNO>NCT01969903</DOCNO>
	<brief_summary>The purpose study find proper amount drug call dexmedetomidine add local anesthetic drug call lidocaine prolong time effect pain relief provide surgery . Dexmedetomidine ( trade name Precedex ) approve U.S. Food Drug Administration ( FDA ) indicate sedation ( calm effect ) . It pain relieve calm effect add lidocaine . In past , addition high amount dexmedetomidine lidocaine decrease blood pressure heart rate . The investigator plan study effect low amount dexmedetomidine achieve level duration pain relief without reduction blood pressure heart rate .</brief_summary>
	<brief_title>Study Use Dexmedetomidine Regional Anesthesia</brief_title>
	<detailed_description>Administered intravenously dexmedetomidine exhibit wide range effect include sedation , analgesia sympathetic activity , translate hemodynamic stability anesthetic dose reduction . Recent several experimental work demonstrate prolongation peripheral nerve block addition dexmedetomidine . One human study substantiate fact 100µg dexmedetomidine add levobupivacaine axillary approach brachial plexus block . This study also show dexmedetomidine use fashion result low systolic diastolic pressure heart rate compare patient receive drug . Bradycardia require treatment atropine occur 7 30 patient ( 23 % ) . The aim randomize prospective study determine optimal dose dexmedetomidine add lidocaine infra- supra-clavicular brachial plexus block . The investigator plan establish dose response relationship use 0.3µg/kg 0.6µg/kg dexmedetomidine add lidocaine , epinephrine bicarbonate mixture infra- supraclavicular brachial plexus block upper extremity surgery . The dos use study substantially low 100 µg dose use levobupivacaine previously . The investigator hypothesis dexmedetomidine add lidocaine dos shorten onset prolong duration brachial plexus block without significant hypotension bradycardia . Significant hypotension define 25 % reduction mean arterial blood pressure baseline reduction mean arterial blood pressure 60 mm Hg . Significant bradycardia define 25 % reduction heart rate baseline heart rate le 50 bpm .</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Patients ( within age range describe ) racial ethnic origin , accept Bellevue Hospital upper extremity surgery , include study . Research include subject regional anesthesia standard care . The patient history hypersensitivity local anesthetic , hematological disease , bleed coagulation abnormality , mental impairment , neurologic disease , unstable cardiac , hepatic , endstage renal , pulmonary coagulation abnormality , history drug abuse include study . Vulnerable subject also exclude study . Patients baseline heart rate lower 65 bpm , blood pressure low 100/60 , know allergy precedex exclude study . Vulnerable subject ( i.e . child , pregnant woman , prisoner , cognitively impair ) exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>brachial plexus block</keyword>
	<keyword>lidocaine</keyword>
	<keyword>dexmedetomidine</keyword>
	<keyword>bradycardia</keyword>
	<keyword>hypotension</keyword>
</DOC>